In continuing coverage, Philadelphia Magazine’s “Be Well Philly” blog reports on a new study by Penn researchers regarding treatment for malignant mesothelioma. The study showed some promising results from a small clinical trial for a new cancer treatment using a modified cold virus to fight mesothelioma, a deadly cancer of the lungs. The treatment, called immuno-gene therapy, entails injecting patients with a small amount of adenovirus, a cold virus—just enough to trigger an immune response. Then, the patient’s own immune defenses take over and start destroying cancer cells... Read More
Learn more about mesothelioma treatment at the Abramson Cancer Center.